ArticleBlood cancer journal2023

Which one is better for refractory/relapsed acute B-cell lymphoblastic leukemia: Single-target (CD19) or dual-target (tandem or sequential CD19/CD22) CAR T-cell therapy?

Sining Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.